Market Overview

Alligator Bioscience Presents at the 20th Annual Rodman & Renshaw Global Investment Conference

Share:

Alligator Bioscience Presents at the 20th Annual Rodman & Renshaw Global Investment Conference

PR Newswire

LUND, Sweden, Aug. 30, 2018 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, announced today that it will be featured as a presenting company at the 20th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held on September 4-6, 2018 at the St. Regis New York Hotel in New York City.

CEO Per Norlén will provide an overview of the Company's business during the live presentation, and will be available to participate in one-on-one meetings with investors who are registered to attend the conference.

Event: Company presentation at the 20th Annual Rodman & Renshaw Global Investment Conference

Date: September 6, 2018

Time: 3:25-3:50 pm EDT (9:25-9:50 pm CEST)

Location: Library (2nd floor); the St. Regis New York Hotel in New York City

The presentation will be webcast live. To access the webcast, please use the direct link http://wsw.com/webcast/rrshq28/atorx/ or visit www.rodmanevents.com. The webcast replay will remain available for 90 days following the live presentation.

For further information, please contact:
Cecilia Hofvander
Director Investor Relations & Communications
Phone +46-46-286-44-95
E-mail: cecilia.hofvander@alligatorbioscience.com 

The information was submitted for publication, through the agency of the contact person set out above, at 2:00 p.m. CEST on August 30, 2018.

About Alligator Bioscience

Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Alligator's growing pipeline includes four lead clinical and pre-clinical drug candidates (ADC-1013, ATOR-1015, ATOR-1017 and ALG.APV-527).

ADC-1013 (JNJ-7107) is licensed to Janssen Biotech, Inc., part of J&J, for global development and commercialization. Alligator's shares are listed on Nasdaq Stockholm (ATORX). The Company is headquartered in Lund, Sweden, and has approximately 50 employees. For more information, please visit www.alligatorbioscience.com.

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/alligator-bioscience/r/alligator-bioscience-presents-at-the-20th-annual-rodman---renshaw-global-investment-conference,c2604652

The following files are available for download:

http://mb.cision.com/Main/12681/2604652/900104.pdf

Alligator Bioscience presents at the 20th Annual Rodman & Renshaw Global Investment Conference

Cision View original content:http://www.prnewswire.com/news-releases/alligator-bioscience-presents-at-the-20th-annual-rodman--renshaw-global-investment-conference-300704777.html

SOURCE Cision AB

View Comments and Join the Discussion!